1. Home
  2. JHS vs BNR Comparison

JHS vs BNR Comparison

Compare JHS & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

N/A

Current Price

$10.43

Market Cap

126.9M

Sector

Finance

ML Signal

N/A

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$16.46

Market Cap

126.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JHS
BNR
Founded
N/A
2014
Country
United States
China
Employees
N/A
N/A
Industry
Finance Companies
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.9M
126.5M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
JHS
BNR
Price
$10.43
$16.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.3K
★ 65.9K
Earning Date
01-01-0001
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$101.46
Revenue Next Year
N/A
$14.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.36
$6.79
52 Week High
$12.09
$41.72

Technical Indicators

Market Signals
Indicator
JHS
BNR
Relative Strength Index (RSI) 22.35 N/A
Support Level N/A N/A
Resistance Level $11.01 N/A
Average True Range (ATR) 0.08 0.00
MACD -0.01 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
JHS
BNR

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: